Purpose & Achievements
Improving Health & Medicine
Research at the Weizmann Institute of Science has led to improved health and better medicine for people everywhere.
Weizmann scientists discovered the basis of amniocentesis and new fertility treatments; discovered Copaxone® and Rebif®, today two of the frontline treatments for multiple sclerosis (MS); and developed a technology used in advanced medical imaging scans.
They are creating diabetes vaccines and flu vaccines; using stem cells to grow new organs and T cells to treat damaged spines; and studying the origins of life and the origins of disease. Institute scientists are also advancing into the future of medicine: at its new Nancy and Stephen Grand Israel National Center for Personalized Medicine, treatments and therapies designed for the individual patient will become a reality.
From understanding the origins of disease to developing the basis for new medicines, the Institute’s basic science research is leading to a healthier world.
Weizmann by the Numbers
-
Weizmann research led to two
of the first-line drugs for treating multiple sclerosis (MS):
Copaxone® and Rebif® -
Chances of pregnancy double after our biopsy-based fertility treatment
-
Prof. Ada Yonath: first woman in 45 years – just the fourth in history – to win the Nobel in Chemistry, and the first Israeli female laureate
Highlights
Why Do Cancer Patients Lose So Much Weight?
Down with MS
Plant Research Reaches a New High
Decades-Old Mystery of Red Blood Cell Production Finally Solved
Putting gene expression in its place
